The expression of the matrix-degrading enzymes collagenase and stromelysin is modulated by a variety of biologic and pharmacologic agents. IFN-y has potent effects on metalloproteinase production and therefore may play an important role in preventing excessive connective tissue degradation during inflammation and repair. We investigated the mechanisms of collagenase and stromelysin regulation by IFN-y in human dermal fibroblasts. IFN-y (300 U/ml) prevented the stimulation of metalloproteinase gene expression by IL-1,8. In addition, incubation of fibroblasts with IFN-y resulted in a marked increase in cellular indoleamine 2,3-dioxygenase (1DO) mRNA, a > 90% depletion of tryptophan, and a corresponding > 30-fold increase in the tryptophan metabolite kynurenine in the culture media. Reducing the concentration of tryptophan from 25 jaM to 0 markedly diminished the ability of fibroblasts to increase collagenase and stromelysin mRNA and collagenase production in response to IL-1p3. Addition of exogenous tryptophan Iug/ml) to cultures that had been tryptophan depleted by pretreatment with IFN-y for 48 h restored the fibroblast response to IL-1,8 or PMA, but had no effect on IFN-yinduced HLA-DR a chain mRNA expression. These results indicate that inhibition of collagenase and stromelysin gene expression by IFN-y in fibroblasts is associated with activation of IDO and enhanced cellular tryptophan metabolism. Tryptophan degradation and ensuing tryptophan depletion may account, at least in part, for the inhibitory effect of IFNy on metalloproteinase production in dermal fibroblasts. (J.
Introduction
A dynamic balance between the deposition and the degradation of connective tissue must be carefully maintained during physiologic tissue remodeling in development, angiogenesis, and wound healing. Alterations in connective tissue turnover are implicated in the degradation of the extracellular matrix (ECM)1 characteristic of pathologic processes, including rheumatoid joint destruction, corneal ulcerations, and tissue invasion by tumors. Fibroblasts and other mesenchymal cells produce several structurally related endopeptidases that are capable of degrading the macromolecules of the ECM (reviewed in references 1 and 2). Interstitial collagenase, the prototypic member of the metalloproteinase family, initiates degradation of native interstitial collagens, whereas stromelysin degrades proteoglycans, laminin, and other matrix components and activates procollagenase in vitro. The production and activity of metalloproteinases are tightly regulated and can be modulated by various extracellular signals. IL-Il#3 stimulates the expression of collagenase and stromelysin genes in a variety of cell types by a combination of transcriptional and posttranscriptional mechanisms (3) (4) (5) (6) . Additional inflammatory mediators, such as TNFa (7) and leukoregulin (8) , are also potent physiologic stimuli for metalloproteinase production in fibroblasts and synovial cells. These cytokines are therefore pivotal in mediating connective tissue destruction in rheumatoid arthritis and related inflammatory conditions (9) .
The interferon family of peptides are highly pleiotropic cytokines that exert immunomodulatory and antiproliferative effects on many cell types both in vitro and in vivo (10) . IFNy is a product of activated T lymphocytes, macrophages, and natural killer cells. It has been shown to modulate the expression of genes for nitric oxide synthetase, tryptophanyl-tRNA synthetase, indoleamine 2,3-dioxygenase (IDO), and other proteins of unknown function (11) (12) (13) . These gene products may be involved in mediating many of the biologic activities associated with IFN-y (14) . In particular, IFN-y-induced activation of IDO, which catalyzes tryptophan oxidation (15) , is considered to be an important mechanism accounting for the antiproliferative effects of IFN--y on some tumor cells (16) (17) (18) (19) and the inhibition of intracellular replication of parasites (20) (21) (22) (23) .
In addition to its well-recognized roles in the immune and inflammatory responses, IFN-y can also influence the metabolism of connective tissue cells. IFN-y regulates collagen accumulation by inhibiting the synthesis of types I and II collagens (24) (25) (26) , abrogating the stimulatory effects of TGF-f3 (27, 28) , and stimulating the expression of collagen receptors on fibroblasts (29) . These effects have been shown to be mediated largely at the pretranslational level (25) (26) (27) (28) . IFN-y by itself, or in combination with inflammatory mediators, also has potent effects on the ability of fibroblasts and other cells to degrade the surrounding ECM (30, 31) . The precise mechanisms involved in this potentially important function of IFN-y have not been fully characterized. In this study, we examined the regulation of metalloproteinase gene expression by IFN--y in cultured human fibroblasts and investigated whether modulation of IDO-mediated cellular tryptophan catabolism plays a role in mediating these effects. The results indicate that IFN-y prevented IL-1,8-or PMA-stimulated collagenase and stromelysin gene expression in fibroblasts and caused a marked increase in IDO activity, resulting in depletion of tryptophan from the culture media. Repletion of tryptophan selectively reversed the IFN-y-induced inhibition of metalloproteinase gene expression. Therefore, the inhibitory effects of IFN-y on IL-l/,-induced collagenase and stromelysin production in human fibroblasts appear to be mediated, at least in part, via induction of IDO and cellular tryptophan catabolism and the consequent depletion of tryptophan.
Methods
Reagents. All tissue culture reagents were obtained from Gibco Laboratories (Grand Island, NY). L-Tryptophan and PMA were obtained from Sigma Chemical Co. (St. Louis, MO). Recombinant human IL-1,8 and IFN-y were from Boehringer Mannheim Biochemicals (Indianapolis, IN). Methanol-water extracts of L-tryptophan used in these experiments were shown by HPLC to contain numerous peaks in addition to tryptophan; the concentration of each peak obtained was < 0.1%, based on comparison of the peak area with the area of the tryptophan peak (Hill, R., personal communication). Therefore, the impurities in the tryptophan preparations represented by the peaks were present in the culture media at very low concentrations (< 250 nM) in these experiments.
Fibroblast cultures. The cell lines used in the present experiments were established from forearm skin biopsies of four healthy adults by explant techniques previously described (32) . Cells Extraction and analysis ofRNA. At the end of each experiment, total RNA was isolated from confluent fibroblasts by the CsCl centrifugation method (34) and subjected to Northern analysis using cDNAs previously labeled with [a-32P]dCTP by nick translation (35) . Autoradiograms were analyzed by scanning at the linear range of the absorbance curve with a laser densitometer (LKB Wallac, Bromma, Sweden). The following cDNAs were used: human collagenase (36), HLA-DR a chain (37) , and rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (38) (40) .
Determination of tryptophan and kynurenine concentrations. Total free tryptophan and kynurenine were assayed by HPLC on a C-18 column eluted isocratically using a solvent of 0.1 M phosphate buffer (pH 3.6 with sodium hydroxide) containing 0.001 M disodium-EDTA and 5% acetonitrile. Samples of culture media were deproteinized with perchloric acid (0.6 M). Tryptophan was detected by its native fluorescence (activation at 290 nm and emission at 360 nm) using a programmable fluorimeter (model HP1046A; Hewlett-Packard Co., Palo Alto, CA). Kynurenine was detected in the same chromatograms by ultraviolet absorption at 360 nm using a UV-1 absorbance detector (Rainin Instrument Co., Woburn, MA) in series with the fluorimeter. Chromatogram recordings and calculations were done using the Dynamax program (Rainin Instrument Co.).
Determination of collagenase levels. Competitive binding ELISAs for human fibroblast collagenase were performed on conditioned medium samples exactly as described previously (41) . This assay measures active and latent, as well as free and bound (enzyme-substrate and enzyme-inhibitor complex) forms of collagenase.
Results
Effect of IFN-y on IL-I-induced collagenase and stromelysin mRNA expression. To examine the effect of IFN-y on collagenase and stromelysin mRNA abundance, IFN-y and IL-lI3 were added to confluent dermal fibroblasts. Following a 24-h incubation, cultures were harvested, and mRNA levels were examined by Northern analysis. As shown in Fig. 1 , untreated fibroblasts displayed very low levels of collagenase and stromelysin mRNAs. As reported previously (6) , exposure of the cultures to IL-l, for 24 Effect ofIFN-y on tryptophan metabolism infibroblast cultures. To determine whether abrogation of the IL-l~3-stimulated increase in collagenase and stromelysin mRNA expression by IFN-y was related to IDO induction, mRNA levels in IFNy-treated fibroblast cultures were examined by Northern hybridization with human IDO cDNA (40) . As shown in Fig. 2 A, IDO mRNA was essentially undetectable in untreated or in IL-Ifi-treated cultures. Exposure of fibroblasts to IFN--y for 48 h, in the presence or absence of IL-If3, caused a marked increase in IDO mRNA levels. As expected, a single transcript with an apparent molecular size of 2.2 kb was observed. The stimulation of IDO mRNA by IFN-y was time and dose dependent, with a maximal effect after a 2 8-h incubation with 2 50 U/ml IFN-y (data not shown).
To examine the effects of IFN-y and IL-16 on IDO-mediated tryptophan metabolism in dermal fibroblasts, tryptophan and kynurenine were measured in the culture supernatants at the end of the incubation period. As shown in Fig. 2 There were no differences in cellular morphology under the phase contrast microscope or in viability, as determined by release of lactate dehydrogenase into the media by fibroblasts maintained in tryptophan-free and tryptophan-containing cultures. By trypan blue dye exclusion, the cultures consistently yielded > 90% viability, and the incorporation of radiolabeled precursors into newly synthesized macromolecules was unaffected by the absence of tryptophan in the cultures for up to 96 h, demonstrating that tryptophan deprivation did not result in significant toxicity to the fibroblasts. Northern analysis of total RNA from untreated and IL-113-treated fibroblasts indicated that stimulation of collagenase and stromelysin mRNA by IL-113 was markedly reduced in the cultures under tryptophan-free conditions (Fig. 3 A) . In contrast, GAPDH mRNA levels were similar in the presence or absence of tryptophan in the media. Identical results were obtained from two separate experiments.
Secreted collagenase was measured by ELISA in cultures of untreated or IL-lp-treated fibroblasts that had been placed at confluence in tryptophan-free media, or in media with tryptophan. As shown in Fig. 3 Effect oftryptophan repletion ofIFN--y -treated cultures on the response to IL-1/3. Since IFN-y induced the degradation of tryptophan in the cultures and fibroblasts under tryptophanfree conditions displayed reduced responsiveness to IL-1p, we speculated that abrogation of IL-1,j-induced metalloproteinase synthesis and mRNA expression by IFN-y was in part due to tryptophan depletion. To test this hypothesis, we examined whether addition of exogenous tryptophan to IFN--y-treated tryptophan-depleted cultures would restore full fibroblast responsiveness to IL-13-induced collagenase and stromelysin gene expression. For this purpose, IFN-y was added to confluent fibroblasts that were maintained in complete media, followed 48 h later by the addition of various concentrations of tryptophan. 24 h later, IL-1/3 was added and the incubation was continued for an additional 32 h. As shown in Fig. 4 (top) , IL-116 caused an increase in collagenase and stromelysin mRNA, whereas pretreatment of cultures with IFN-y reduced this stimulation by > 80%. Treatment with IFN-y for 48 h also caused a > 90% decrease in the concentration of tryptophan in the culture media (data not shown). In the presence of increasing concentrations of tryptophan, addition of IL-1/3 to the IFN-ytreated cultures caused a progressive increase in collagenase and stromelysin mRNA, such that 50 j.g/ml tryptophan completely overcame the IFN-y-induced inhibition (Fig. 4, top) . In the absence of IL-1,6, addition of tryptophan to untreated or IFNy-treated cultures appeared to have no effect on collagenase or stromelysin mRNA levels. To control for nonspecific effects of tryptophan, mRNA was hybridized to DRI, a cDNA for the human HLA-DR a chain (37) . The tryptophan did not interfere with the fibroblast response to IFNy in a nonspecific manner. Quantitation of collagenase in the conditioned media by ELISA indicated that pretreatment of the cultures with IFN-y caused a > 70% reduction in the IL-1/3-induced stimulation of collagenase production (Fig. 5) . Addition of tryptophan to cultures treated with IFN-y plus IL-1/ restored the ability of fibroblasts to produce large quantities of collagenase. Exogenous tryptophan overcame the inhibitory effects of IFN-'y on upregulated collagenase and stromelysin mRNA expression induced not only by IL-1/3, but also by the tumor promoter PMA at 160 nM (data not shown).
Discussion
In pathologic conditions, quiescent mesenchymal cells attain a matrix-degrading phenotype upon their interaction with inflammatory cells. Inflammatory cell-derived cytokines, alone or in combination, regulate the production and activity of matrix-degrading enzymes and are therefore considered to play a central role in the initiation of connective tissue degradation (9) . The present results demonstrate that in human dermal fibroblasts, IFN-y prevented the increase in collagenase and stromelysin mRNA and collagenase production induced by IL-1,6.
The inhibitory effect was maximal when cultures were exposed to IFN-y before IL-1,6, suggesting that fibroblasts needed to be primed for IL-1,6 resistance. These results, which are consistent with a previous report (30) , indicate that IFN-y exerts sustained negative effects on the production and activity of matrix-degrading enzymes and suggest that IFN--y may play an important role in preventing excessive connective tissue degradation in physiologic conditions. Activation of transcription by IFN-,y has been extensively studied ( 14) , but the inhibitory effects of this cytokine on gene expression are less well understood. To investigate the mechanisms by which IFN-,y prevented IL-1I3-induced expression of metalloproteinase genes in fibroblasts, we examined the regulation of IDO by these cytokines. IDO (EC 1.13.11.17), an enzyme widely distributed in mammalian extrahepatic tissues, catalyzes the first step in the degradation of tryptophan (42) . This step, involving the incorporation of molecular oxygen or superoxide anion, results in decylization of the tryptophan pyrrole ring and formation of N-formylkynurenine (16, 43) . We found that whereas treatment of the fibroblasts with IL-1,f had no effect on IDO mRNA levels, IFN--y by itself or in combination with IL-1I3 caused a marked increase. IFN-'y was previously shown to activate the transcription of IDO in human fibroblasts ( 13, 44) . Although the biologic significance of IDO unknown, it has been suggested that it represents an antioxidant defense mechanism during the inflammatory response (45). After exposure to IFN-y, the uptake and IDO-mediated intracellular oxidation of tryptophan are dramatically increased in cultured mammalian cells (20 on metalloproteinase gene expression. The results showed that addition of tryptophan to fibroblasts pretreated with IFN-y reversed the inhibitory effects of IFN-,y, while having no effect on IFN-y-induced HLA-DR a chain mRNA levels. Taken together, these results strongly suggest that tryptophan is required for maximal stimulation of collagenase and stromelysin gene expression in dermal fibroblasts. Although it is the least abundant amino acid in mammalian proteins, tryptophan serves as a metabolic precursor for biologically important amines (see reference 48 for review) and has been shown to stimulate protein synthesis independent of its function as a precursor amino acid (49) (50) (51) . We recently reported that at supraphysiologic concentrations (:2 500 ,ug/ml), tryptophan, but not other amino acids, caused transcriptional stimulation of collagenase gene expression in human fibroblasts (33) . Since tryptophan appears to be important in the regulation of several biologic processes, IDO-mediated cellular tryptophan catabolism and the ensuing tryptophan starvation may have pleiotropic effects. Indeed, the antiproliferative activity of IFN-y on some tumor cells can be attributed to the intracellular depletion of tryptophan (16) (17) (18) (19) . Similarly, the inhibitory effects of IFN-y on the intracellular growth of certain parasites, such as Toxoplasma gondii in human fibroblasts and glioblastoma cells (20, 22) and Chlamydia psittaci in human macrophages and bladder carcinoma cell lines (21, 23) , appear to be due, at least in part, to enhanced IDO-mediated tryptophan catabolism in the host cells. Overexpression of IDO in a transformed human fibroblast line markedly inhibited the proliferation of transfected cells, and this effect was correlated with depletion of tryptophan from the media (52) . Furthermore, in mutant ME180 human cervical carcinoma lines, which are deficient in IDO activity and therefore unable to catabolize tryptophan, IFN-y failed to inhibit
